Cardiovascular diseases(CVDs)are the global leading cause of mortality,being responsible for over 17.7 million deaths annually[1].In China,the number of patients with cardiovascular diseases has reached 330 million and accounts for more than 43%of deaths caused by diseases-a much higher proportion than that of cancer,respiratory diseases,or other diseases[2].Among such diseases,coronary heart disease(CHD)and structural heart disease(SHD)are common CVDs with the highest risk.In recent years,implanta-ble materials and devices-especially minimally invasive interven-tional ones-have become the most effective tools for the treatment of cardiovascular diseases.Examples of such tools include vascular stents,drug-eluting balloons,heart valves,cardiac occluders,artificial grafts,injectable hydrogels against heart fail-ure,and left ventricular assist devices(LVADs)[3,4].